相关实验视频

Updated: Jun 13, 2025

The 6-hydroxydopamine Rat Model of Parkinson's Disease

The 6-hydroxydopamine Rat Model of Parkinson's Disease

Published on: October 27, 2021

使用6-OHDA进行帕金森病的体外建模与增加的NQO2活性有关

Ekaterina R Verbovaya¹, Ilya A Kadnikov¹, Ilya O Logvinov²

¹Laboratory of Pharmacogenetics, Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, Baltiyskaya Street 8, 125315 Moscow, Russia.

Toxicology in vitro : an international journal published in association with BIBRA

|September 13, 2024

概括

氨酸减少酶2 (NQO2) 活性随着6-氧多巴胺 (6-OHDA) 诱导的细胞损伤而增加,这表明它在帕金森病的发病过程中的作用. 这项研究建立了一个评估NQO2抑制剂的模型.

科学领域:

神经科学是一个神经科学.
生物化学生物化学
细胞生物学细胞生物学

背景情况:

帕金森病 (PD) 的发病过程涉及甲基荷胺代谢中断.
氨酸还原酶2 (NQO2) 从甲醇胺代谢物中产生反应性氧物种 (ROS),这意味着它与PD相关的细胞损伤有关.

研究的目的:

为了研究6-二多巴胺 (6-OHDA) 诱导的细胞损伤和SH-SY5Y细胞中的NQO2活性/水平之间的联系.
建立一个实验模型来评估NQO2抑制剂在PD的背景下.

主要方法:

用6-OHDA化SH-SY5Y细胞以诱导氧化损伤.
用MTT和彗星测定来评估细胞损伤.
随着时间的推移和在不同6OHDA度下测量了NQO2活性和蛋白质水平.

主要成果:

在SH-SY5Y细胞中引起的6-OHDA氧化损伤与增加的NQO2活性相关.
在6 -OHDA (50和100微米) 的潜伏后24小时观察到高的NQO2蛋白水平.
共同基质1--1,4-二氨基胺 (BNAH) 增强了6-OHDA的毒性,但没有改变NQO2水平,证实了NQO2的细胞毒性贡献.

结论:

作为对6-OHDA诱导的细胞损伤的反应,NQO2活性和水平受到上调.
在6-OHDA神经毒性背后的细胞毒性机制中,NQO2起着重要作用.
这项研究为开发NQO2抑制剂作为帕金森病潜在治疗剂提供了基础.

关键词:

6-OHDA 是一个6 -OHDA的元素.彗星测量试验方法氧化作用的损伤.昆减少酶2的作用是什么在SH-SY5Y细胞中.

更多相关视频

Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test

Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test

Published on: January 15, 2010

Development of a Unilaterally-lesioned 6-OHDA Mouse Model of Parkinson's Disease

Development of a Unilaterally-lesioned 6-OHDA Mouse Model of Parkinson's Disease

Published on: February 14, 2012

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...